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Abstract
Purpose: The assessment of inducible wall motion abnormalities during high-dose dobutamine-stress cardiovascular
magnetic resonance (DCMR) is well established for the identification of myocardial ischemia at 1.5 Tesla. Its feasibility at
higher field strengths has not been reported. The present study was performed to prospectively determine the feasibility
and diagnostic accuracy of DCMR at 3 Tesla for depicting hemodynamically significant coronary artery stenosis (≥ 50%
diameter stenosis) in patients with suspected or known coronary artery disease (CAD).
Materials and methods: Thirty consecutive patients (6 women) (66 ± 9.3 years) were scheduled for DCMR between
January and May 2007 for detection of coronary artery disease. Patients were examined with a Philips Achieva 3 Tesla
system (Philips Healthcare, Best, The Netherlands), using a spoiled gradient echo cine sequence. Technical parameters
were: spatial resolution 2 × 2 × 8 mm3, 30 heart phases, spoiled gradient echo TR/TE: 4.5/2.6 msec, flip angle 15°. Images
were acquired at rest and stress in accordance with a standardized high-dose dobutamine-atropine protocol during short
breath-holds in three short and three long-axis views. Dobutamine was administered using a standard protocol (10 μg
increments every 3 minutes up to 40 μg dobutamine/kg body weight/minute plus atropine if required to reach target
heart rate). The study protocol included administration of 0.1 mmol/kg/body weight Gd-DTPA before the cine images
at rest were acquired to improve the image quality. The examination was terminated if new or worsening wall-motion
abnormalities or chest pain occurred or when > 85% of age-predicted maximum heart rate was reached. Myocardial
ischemia was defined as new onset of wall-motion abnormality in at least one segment. In addition, late gadolinium
enhancement (LGE) was performed. Images were evaluated by two blinded readers. Diagnostic accuracy was determined
with coronary angiography as the reference standard. Image quality and wall-motion at rest and maximum stress level
were evaluated using a four-point scale.
Results: In 27 patients DCMR was performed successfully, no patient had to be excluded due to insufficient image
quality. Twenty-two patients were examined by coronary angiography, which depicted significant stenosis in 68.2% of the
patients. Patient-based sensitivity and specificity were 80.0% and 85.7% respectively and accuracy was 81.8%.
Interobserver variability for assessment of wall motion abnormalities was 88% (κ = 0.760; p < 0.0001). Negative and
positive predictive values were 66.7% and 92.3%, respectively. No significant differences in average image quality at rest
versus stress for short or long-axis cine images were found.
Conclusion: High-dose DCMR at 3T is feasible and an accurate method to depict significant coronary artery stenosis
in patients with suspected or known CAD.
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Introduction
Several studies performed at different sites have demon-
strated high diagnostic accuracy for high-dose dob-
utamine stress cardiovascular magnetic resonance
(DCMR) at 1.5 Tesla to identify the presence of coronary
artery stenoses and define the functional relevance of
these lesions [1,2]. In patients with reduced image quality
in stress echocardiography the superiority of DCMR was
demonstrated [3,4].
Early DCMR studies performed at 1.5 Tesla used Turbo
Gradient Echo Sequences (TGrE) [3-5]. Later, balanced
steady-state free precession (SSFP) became the gold stand-
ard for cine CMR at 1.5 Tesla [6] and was also routinely
used for DCMR [7,8]. However, increased B0 and B1
inhomogeneity at 3 Tesla compared to 1.5 Tesla led to
problems with off-resonance artifacts, limiting the use of
the current standard SSFP cardiac cine-imaging. Com-
pared to SSFP sequences, TGrE techniques have the advan-
tage of causing very few artifacts. However, one of the
disadvantages of TGrE cine-images is the relatively low
contrast between blood-pool and myocardium. Especially
in the long-axis planes and in patients with impaired LV
function the image quality is limited by reduced signal
intensity of the blood due to saturation of blood flowing
predominantly in plane, which may hinder LV endocar-
dial border delineation and therefore functional assess-
ment [9].
To overcome these limitations, we recently demonstrated
that the application of an extracellular contrast agent
before the acquisition of TGrE cine-images, improves
image quality and blood-to-myocardium contrast in long-
axis views and leads to better endocardial border delinea-
tion as compared with native long-axis cine-imaging at 3
Tesla [10]. Based on these results, we hypothesize that
high-dose DCMR in combination with contrast agent
administration at 3 Tesla is feasible by using TGrE cine
sequences to detect significant coronary stenoses in
patients with clinically suspected or known CAD. Thus,
the purpose of our study was to prospectively determine
the feasibility and diagnostic accuracy of high-dose
DCMR using a 3 Tesla scanner for depicting clinically sig-
nificant coronary artery stenoses in patients with sus-
pected or known coronary artery disease (CAD).
Materials and methods
Patient population
The study was conducted in accordance with the stand-
ards of the Charité institutional review board. Patients
with suspected or known coronary artery disease and
recurrent angina, including patients with a history of
myocardial infarction and previous percutaneous coro-
nary intervention (PCI), were prospectively enrolled after
giving written informed consent. Thirty patients (24 men
and 6 women; mean age, 66 ± 9.3 years) scheduled for
clinically indicated coronary angiography with suspected
or known coronary artery disease were studied between
January and May 2007. Patients were excluded if they had
typical contraindications for CMR (non-compatible bio-
metallic implants or claustrophobia) or administration of
dobutamine or known arrhythmias [11,12]. Patients who
had previously undergone coronary artery bypass graft
surgery were not included (table 1).
All patients were instructed to refrain from β-blocker treat-
ment 24 hours before CMR. The medical history of the
patients was recorded at the time of CMR.
CMR examination
All patients were examined in supine position using a 3 T
whole-body MR system (Achieva 3T; Philips Healthcare,
Best, The Netherlands) equipped with a Quasar Dual gra-
dient system (80 mT/m, 200 T/m/s slew rate). A six-ele-
ment cardiac synergy coil was used for signal detection.
Cardiac synchronization was performed by a four elec-
trode vector electrocardiogram, and image acquisitions
were triggered on the R-wave [13]. The images were
acquired in expiratory breath-holds.
Imaging protocol
All patients received one 18 gauge intravenous line to
allow administration of dobutamine and the contrast
Table 1: Patient demographics of 30 patients.
Patient characteristics
Sex, F/M 6/24
Age, y 66 ± 9.4
Range 48 – 54
BMI, kg/m2 27 ± 30
Medical history information, n (%)
Hypertension 24 (80)
Diabetes mellitus 11 (36.7)
Hyperlipoproteinemia 15 (50)
History of smoking 9 (30)
Family history of CAD 10 (33.3)
Suspected CAD 9 (30)
Known CAD 21 (70)
Previous PCI 17 (56.7)




BMI = body mass index; CAD = coronary artery disease; PCI = 
percutaneous coronary intervention; CABG = coronary artery bypass 
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agent. The patients underwent a standardized CMR exam-
ination including the following steps, as demonstrated in
figure 1:
1. Localization of the heart in the three standard planes
(transversal, coronal and sagittal) using a rapid gradient
echo sequence (multistack, multislice survey scan, TGrE,
TR/TE/flip angle = 3.6 msec/1.7 msec/20°).
2. Cine-imaging of three short-axis views and long-axis
views (four-chamber; two-chamber and three-chamber
view). A spoiled gradient echo cine sequence was used.
Technical parameters were: spatial resolution 2 × 2 × 8
mm3, 30 heart phases, spoiled gradient echo TR/TE = 4.5/
2.6 msec, flip angle 15°. The breathhold duration per slice
acquired was kept at approximately 10 sec. To accommo-
date the wide range of heart rates in the stress protocol (46
to 147 beats per minute), the number of k-space lines
acquired for each cardiac phase per heart beat (TFE factor)
had to be adjusted from 19 to 6. Accordingly, the acquired
temporal resolution ranged from 83 to 39 msec, and was
interpolated to 44 to 20 msec using a sliding window
reconstruction. The three short-axis views were distributed
to cover the heart at the basal, equatorial and apical posi-
tion by adjusting the gap between the sections. Before the
acquisition of cine short-axis images at rest was started, an
intravenous bolus of 0.1 mmol/kg Gd-DTPA (Magnevist®,
Schering, Berlin, Germany) at an injection rate of 2 ml/s
followed by a flush of 20 ml of saline solution at the same
rate was administered.
3. DCMR using the described cine sequence at every step
of dobutamine administration. Dobutamine (10 to a
maximum of 40 μg/min/kg body weight) was given for a
total of 3 minutes at every step. Imaging was performed
after 1 minute infusion of dobutamine at every step and
required around 2 minutes. Up to 2 mg Atropine was
administered if targeted heart frequency could not be
reached. ECG rhythm and symptoms were monitored
continuously and blood pressure was ascertained every 3
minutes. Standard termination criteria were used [7,14].
Adverse effects were recorded using a standardized report-
ing form. The stress test itself took around 20 minutes.
4. An additional bolus of 0.1 mmol/kg body weight Gd-
DTPA given immediately after the last stress scan and fol-
lowed by late gadolinium enhancement (LGE) 10–15
minutes later. LGE imaging was performed using an inver-
sion prepared 3D spoiled gradient echo sequence (1.5 ×
1.7 × 5 mm3). The whole protocol lasted around 45 min-
utes, similar in comparison to studies at 1.5 Tesla.
Image analysis
Images were evaluated independently by two experienced
readers blinded to the patients' history and angiographic
results using a synchronized quad-screen image display
and applying the standard scoring system (1 = normoki-
netic; 2 = hypokinetic; 3 = akinetic and 4 = dyskinetic). For
determination of left ventricular ejection fraction and left
ventricular end-systolic and end-diastolic volumes, three
short-axis views and two long-axis views (four-chamber
and two-chamber) were used. All myocardial segments
were assigned to the three major coronary arteries in
Time course of dobutamine stress CMR examination at 3 Tesla Figure 1
Time course of dobutamine stress CMR examination at 3 Tesla.
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accordance with common definitions [15]. Ischemia was
defined if ≥ 1 segment showed new wall motion abnor-
malities (increase of wall-motion score at stress) or if a
biphasic response was demonstrated in areas with resting
wall-motion abnormalities.
The image quality of each standard view (long and short
axis) and, according to myocardial vascularization, of the
four myocardial regions (anterior, lateral, inferior and
septal) was rated on a 4-point scale for the visibility of the
endocardial border (score 1 = poor or nondiagnostic; 2 =
partial or moderate visibility; 3 = good visibility; and 4 =
excellent visibility [10].
Coronary angiography
Conventional coronary catheterization was performed
within 7 ± 12 days after the CMR examination using a
standard Judkins technique. A reduction of the luminal
diameter ≥ 50% in one of the major epicardial coronary
arteries or their major branches (≥ 2 mm) was defined as
a hemodynamically significant stenosis. The stenosis
severity was defined quantitatively by an experienced
interventionalist blinded to the results of CMR.
Statistical analysis
Statistical analysis was performed using SPSS for Win-
dows (Statistical Package for Social Sciences (SPSS),
release 12.0.1; Chicago, USA); for all continuous parame-
ters, mean ± standard deviation is given. The paired Stu-
dent's t-test was used to assess statistical significance of
continuous variables. Sensitivity, specificity and diagnos-
tic accuracy as well as negative and positive predictive val-
ues on a patient-based analysis were calculated according
to standard definitions. For comparison of interobserver
variability for the assessment of wall-motion abnormali-
ties on a patient basis and in myocardial territories, kappa
values were calculated. The Wilcoxon signed-rank test was
used to evaluate the statistical correlation between the vis-
ual score of TgrE cine images at rest and at maximum
stress. A p < 0.05 was considered statistically significant.
Results
Study group
For a detailed description of patients' hemodynamic data
at rest and during stress see table 2.
In 3 (10%) of 30 patients the examinations had to be ter-
minated at stress due to ECG-trigger problems which pro-
hibited further data acquisition. One patient developed
severe angina pectoris at maximum stress and requested
termination of the examination; the symptoms resolved
after administration of nitrates. Of the remaining 27
patients, 22 were available for comparative examination
by coronary angiography. The average dosage of dob-
utamine and atropine was 36.3 ± 5.5 μg/min/kg body
weight and 0.2 ± 0.4 mg, respectively.
Diagnostic performance
Typical image quality at rest and stress are presented in fig-
ure 2. Hemodynamically significant coronary artery sten-
oses were present in 68.2% (15/22) of patients. The
overall patient-based sensitivity, specificity and diagnostic
accuracy for the detection of significant coronary artery
stenosis (≥ 50%) were 80.0%; 85.7% and 81.8%, respec-
tively (figure 3). Negative and positive predictive values
were 66.7% and 92.3%, respectively. Figure 4 shows an
example of a positive dobutamine stress study in a patient
with obstructive coronary artery disease.
Interobserver agreement
There was agreement in the determination of myocardial
wall-motion abnormalities in 88% of the patients (κ =
0.760; p < 0.0001) on a per patient basis, in 100% of the
LAD segments (κ = 1; p < 0.0001), 72% of LCX segments
(κ = 0.426; p = 0.009) and 80% of the RCA segments (κ =
0.429; p = 0.022).
Table 2: Hemodynamic data.
Left ventricular function (rest)
LVEF, % 56.4 ± 6.8
LVEDV, ml 134.2 ± 31.7
LVESV, ml 60.9 ± 20.9
Heart rate, bpm
At rest 63.3 ± 9.2
Maximum stress 123.1 ± 20.9
Systolic blood pressure, mmHg
At rest 133.9 ± 20.7
Maximum stress 131.7 ± 29.2
Diastolic blood pressure, mmHg
At rest 77.0 ± 11.9
Maximum stress 72.9 ± 15.6
Heart rate-pressure product, bpm × mmHg
At rest 8505.2 ± 1956.9
Maximum stress 9709.6 ± 2541.7
Values are expressed as mean ± standard deviation. LVEF = left 
ventricular ejection fraction; LVEDV = left ventricular end-diastolic 
volume; LVESV = left ventricular end-systolic volume; bpm = beats 
per minute. Heart rate – pressure product is heart rate times systolic 
blood pressure.Journal of Cardiovascular Magnetic Resonance 2008, 10:44 http://www.jcmr-online.com/content/10/1/44
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Image quality at rest and maximum dobutamine stress
All examinations in both, rest and maximum stress cine-
imaging yielded diagnostic image quality (minimum
average score for a single slice orientation or myocardial
region > 2.7). In short-axis views, the average image qual-
ity score differed at rest between the slice orientations,
demonstrating the highest value for the basal short axis
and decreasing to the lowest value for the apex. In every
slice orientation there was a nonsignificant tendency
towards decreased average image quality score at stress,
compared to rest. In long-axis views; average image qual-
ity at stress tended to be reduced at peak stress in compar-
ison to rest (Figure 5).
No significant difference could be found in average image
quality score between rest and stress, arranged in accord-
ance to the four myocardial regions (anterior, lateral, infe-
rior and septal wall) (Table 3).
Discussion
In recent years, 3 Tesla CMR has become available and has
demonstrated advantages over 1.5 Tesla over a broad
range of applications, for example perfusion imaging
[16,17]; late gadolinium enhancement [18]; peripheral
MR angiography [19,20] and coronary magnetic reso-
nance imaging [21].
The feasibility, accuracy, safety and prognostic value of
high-dose DCMR at 1.5 Tesla in a wide range of patients
is known to identify the presence of coronary artery sten-
oses and define the functional relevance of these lesions
[1,2]. The assessment of inducible wall-motion abnor-
malities during high dose DCMR at 3 Tesla has not been
systematically studied.
We have recently shown, that the administration of Gd-
DTPA results in a significant improvement of contrast
between blood and myocardium when using TGrE cine
imaging at 3 Tesla [10]. In the current study we use a sim-
ilar approach using Gd-DTPA. This resulted in a good
image quality score in both rest and maximum stress cine-
imaging examinations. The diagnostic image quality was
yielded with a minimum average score for a single slice
orientation or myocardial region > 2.7. Due to the use of
TGrE cine-imaging and the relatively low flow velocity in
the apical slice, the contrast between myocardium and
blood was lower in the apical segments at rest and stress
compared to the other myocardial segments. We found a
Dobutamine stress CMR demonstrates no wall motion abnormalities at rest or at maximum stress Figure 2
Dobutamine stress CMR demonstrates no wall motion abnormalities at rest or at maximum stress. In invasive 
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slightly decreased average image quality score in every
slice orientation at stress, compared to rest, but this was
not statistically significant. By using this approach in all
patients there was complete agreement in the determina-
tion of myocardial wall-motion abnormalities in 88% of
the patients (κ = 0.760; p < 0.0001) on a per patient basis.
Recent reports have identified a possible link between a
new scleroderma-like disorder, nephrogenic systemic
fibrosis (NSF), and exposure to contrast agents containing
gadolinium in patients with severe renal insufficiency.
Therefore, the US Food and Drug Administration (FDA)
and European medicines agencies recommend that in
patients with severe renal impairment, agents containing
gadolinium should be used only if clinically essential
[22]. In our patient population, no subject presented
severe renal impairment. However, to assess obstructive
coronary artery disease, scar imaging should be per-
formed. In recent studies in CAD and diabetes patients,
the prognostic value of scar imaging was demonstrated
[23,24]. In our study we did not report the results of scar
imaging, because the readers were not blinded to the scar
imaging results when they reviewed the wall-motion stud-
ies. Advantages of 3 T versus 1.5 T, especially for LGE,
seem to be the possibility of a reduced contrast agent dose
[25] and higher achievable spatial and temporal resolu-
tion [18].
ECG-trigger problems made it impossible to acquire data
in three (10%) patients at peak stress. At higher field
strength (3 Tesla), the magneto-hydrodynamic effect is
enhanced and leads to an artifactual voltage overlayed on
the T-wave of the ECG. This effect becomes more pro-
nounced altering high-dose dobutamine stress, since flow
in the aorta increases. This artifactual augmentation of the
T-wave may mislead the R-wave detection algorithm,
causing triggering on the T-wave instead of the R-wave.
This problem may be overcome with sophisticated R-wave
detection algorithms [13], which have been shown to be
very reliable at rest [26]. One patient developed severe
angina pectoris at maximum stress and requested termi-
nation of the examination; the symptoms resolved after
administration of nitrates. This is within the range of the
previously reported tolerance and safety profile of high-
dose DCMR studies at 1.5 Tesla [27].
The diagnostic accuracy we report for high-dose DCMR at
3 Tesla in our study is within the range of previously pub-
lished data on DCMR at 1.5 Tesla. A recently published
meta-analysis pooled 13 CMR studies performed in 735
patients for stress-induced wall motion abnormalities and
reported an overall sensitivity of 83% (95% confidence
interval [25] 79 to 88%) and specificity of 0.86 (95% CI:
81 to 91%) for CAD at subject level. The prevalence of
CAD in this patient group was 70.5% [2]. In our patient
population with a similar prevalence of CAD of 73.5%,
the sensitivity of 80% and specificity of 85.7% are compa-
rable to the reported results.
However, given the more complex acquisition protocol
requiring contrast agent administration and the tenden-
tially lower diagnostic accuracy in comparison to own
data at 1.5 Tesla, we currently see no advantage in using 3
Tesla over 1.5 Tesla for high-dose DCMR. Potentially, the
combination with tagging techniques, which profit from
the higher field strengths, may lead to improved results
for 3 Tesla.
Limitations
The major limitation of our study is the limited number
of patients, which only allows a preliminary statement on
diagnostic accuracy. In addition, the results represent a
single center experience. Patients were only examined at 3
Tesla and no direct comparison to 1.5 Tesla is available.
However, our aim was to establish a clinically robust
approach for high-dose dobutamine CMR at 3 Tesla.
Conclusion and future directions
High-dose dobutamine CMR at 3 Tesla is feasible and has
been demonstrated to be an accurate method to detect
hemodynamically significant coronary stenosis in this
small patient group with suspected or known CAD. Larger
Sensitivity and specificity derived from ROC analysis for  occurrence of dobutamine wall motion abnormalities in pres- ence of coronary stenosis ≥50% Figure 3
Sensitivity and specificity derived from ROC analysis 
for occurrence of dobutamine wall motion abnormal-
ities in presence of coronary stenosis ≥50%. AUC 
indicates area under the curve.
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Stress-induced ischemia (biphasic response) of the infero and infero-lateral wall in a patient with subtotal occlusion of the  proximal and distal left circumflex artery (LCX) (white arrows) Figure 4
Stress-induced ischemia (biphasic response) of the infero and infero-lateral wall in a patient with subtotal 
occlusion of the proximal and distal left circumflex artery (LCX) (white arrows). Improvement at 20 ug/kg/min 
dobutamine of the wall motion abnormality at rest, however, decreased wall motion at maximum stress level. Late gadolinium 
enhancement revealed a 50% subendocardial infarction in this region.




Average visual score for endocardial border delineation for short-axis and long-axis cine-imaging at rest and maximum dob- utamine stress Figure 5
Average visual score for endocardial border delineation for short-axis and long-axis cine-imaging at rest and 
maximum dobutamine stress. Values are expressed as mean + one standard deviation. 4 ch = four-chamber view; 2 ch = 
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trials are needed to establish the clinical role of CMR with
3 Tesla for the detection of CAD.
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